[1]
Biasotti, Michael C. Management
of the severely mentally ill and its effects on homeland security. Naval
Postgraduate School Monterey Ca. Dept. of National Security Affairs, 2011.
[2]
Biasotti, Michael C. Management
of the severely mentally ill and its effects on homeland security. Naval
Postgraduate School Monterey Ca. Dept. of National Security Affairs, 2011.
[3]
Substance Abuse and Mental Health Services Administration. (2013). Results from
the 2012 National Survey on Drug Use and Health: Mental Health Findings.
NSDUH Series H-47, HHS Publication No. (SMA)
13-4805.
[4]
Valenstein, M., Copeland, L., Blow, F., et al. (2002). Pharmacy data identify
poorly adherent patients with schizophrenia at increased risk for admission.
Med Care 40:630–639.
Weiden, P., Kozma, C.,
Grogg, A., et al. (2004). Partial compliance and risk of rehospitalization
among California Medicaid patients with schizophrenia. Psychiatric Services 55:886–891.
Gilmer, T., Dolder, C., Lacro,
J., et al. (2004). Adherence to treatment with antipsychotic medication and
health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry
161:692–699.
Ascher-Svanum, H., Faries,
D., Zhu, B., et al. (2006). Medication adherence and long-term functional
outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry 67:453–460.
Velligan, D., Weiden, P.,
Sajatovic, M., Scott, J., Carpenter, D., Ross, R., Docherty, J., (2009). The
expert consensus guideline series: adherence problems in patients with serious
and persistent mental illness. Journal of
Clinical Psychiatry. 70 Suppl 4:1-46; quiz 47-8.
[5]
Muller-Oerlinghausen, B., Muser-Causemann, B. & Volk, J. (1992). Suicides
and parasuicides in a high-risk patient group on and off lithium long-term
medication.
Journal of Affective
Disorders,
25(4),261-269.
Leucht S., Heres S. (2006).
Epidemiology, clinical consequences, and psychosocial treatment of nonadherence
in schizophrenia. Journal of Clinical Psychiatry, 67(Suppl. 5), 3–8.
Nordentoft, M. (2007).
Prevention of suicide and attempted suicide in Denmark. Epidemiological studies
of suicide and intervention studies in selected risk groups. Danish Medical Bulletin, 54(4),306-69.
Chapman, S.C., Horne, R.
(2013). Medication nonadherence and psychiatry. Current Opinion in Psychiatry, 26(5),446-552.
[6]
Hiday, V., et al. (1999). Criminal Victimization of Persons with Severe Mental
Illness.
Psychiatric Services, 50,
62-68.*
*Individuals with severe
psychiatric disorders who were not taking medication were found to be 2.7 times
more likely to be the victim of a violent crime (assault, rape, or mugging)
than the general population.
[7]
Swartz, M., Swanson, J., Hiday, V., Borum, R., Wagner, H., Burns, B. (1998). Violence
and severe mental illness: The effects of substance abuse and nonadherence to
medication.
American Journal of
Psychiatry, 155, 226-31.
Substance abuse, medication
non-compliance and low insight into illness operate together to increase
violence risk. Van Dorn, R., Volavka, J., Johnson, N. (2011). Mental disorder
and violence: is there a relationship beyond substance use? Social Psychiatry and Psychiatric
Epidemiology.
Witt, K., Van Dorn, R., Fazel, S. (2013). Risk factors for violence in
psychosis: Systematic review and metaregression analysis of 110 studies. PLOS ONE, 8,
e55942.
Belli, H., Ozcetin, A., Erteum, U., et al. (2010). Perpetrators of
homicide with schizophrenia: sociodemographic characteristics and clinical
factors in the eastern region of Turkey. Comprehensive
Psychiatry, 51,135-41.
Alia-Klein, N., O’Rourke, T., Goldstein, R., et al. (2007). Insight into
illness and adherence to psychotropic medications are separately associated
with violence severity in a forensic sample. Aggressive Behavior, 33,
86–96.
Elbogen, E., Van Dorn, A., Swanson JW, et al. (2006). Treatment
engagement and violence risk in mental disorders. British Journal of Psychiatry, 189,354–360.
Swanson, J., Swartz, M., Essock, S., et al. (2002). The
social-environmental context of violent behavior in persons treated for severe
mental illness. American Journal of
Public Health, 92, 1523–1531.
Bartels, J., Drake, R., Wallach, M., et al. (1991). Characteristic
hostility in schizophrenic outpatients. Schizophrenia Bulletin, 17, 163–171.
[8]
Robinson, D. (2010). First-episode schizophrenia.
CNS Spectrum, 15 (Supplement 6), 4-7.
Ayuso-Gutierrez, J., Del
Rio, V. (1997). Factors influencing relapse in the long-term course of
schizophrenia. Schizophrenic Research,
28, 199-206.
Morken, G., Widen, J.,
Grawe, R. (2008). Non-adherence to antipsychotic medication, relapse and
rehospitalisation in recent-onset schizophrenia. BMC Psychiatry, 8,32-8.
Suppes, T., Baldessarini,
R., Faedda, G., Tohen, M. (1991). Risk of recurrence following discontinuation
of lithium treatment in bipolar disorder.
Archives of General Psychology,
48(12),1082-1088.
Franks, M., Macritchie, K.,
Mahmood, T., Young, A. (2008) Bouncing back: is the bipolar rebound phenomenon
peculiar to lithium? A retrospective naturalistic study. Journal of Psychopharmacology, 22(4), 452-456.
[9]
Munetz, M.R., Grande, T.P., & Chambers, M.R. (2001). The incarceration of
individuals with severe mental disorders.
Community
Mental Health, 34:361-71.* * Nearly 90 percent of a sample of individuals
with severe mental illness in a local jail were partially or completely
non-complaint with medication in the year before they were incarcerated.
Lattimore, P. K., Broner,
N., Sherman, R., Frisman, L., & Shafer, M. S. (2003). A comparison of prebooking
and postbooking diversion programs for mentally ill substance-using individuals
with justice involvement. Journal of
Contemporary Criminal Justice, 19(1), 30-64.* *Individuals with
co-occurring mental illness and substance abuse who are noncompliant with
medication have a threefold increase in risk for arrest and are significantly
more likely to be at risk for violent behavior.
Ascher-Svanum, H., Nyhuis,
A.W., Faries, D.E., Ball D.E., & Kinon B.J. (2010). Involvement in the US
criminal justice system and cost implications for persons treated for
schizophrenia. BMC Psychiatry, 10:11.
Shelton, D., Ehret, M. J.,
Wakai, S., Kapetanovic, T., & Moran, M. (2010). Psychotropic medication
adherence in correctional facilities: A review of the literature. Journal of Psychiatric and Mental Health
Nursing, 17(7), 603-613.
[10]
Torrey, EF, Zdanowicz, MT, Kennard, AD, et al. The treatment of persons with
mental illness in prisons and jails: a state survey. Treatment
Advocacy Center and National Sheriff’s
Association, April 8, 2014.
[11]
Swartz, M., Swanson, J., Wagner, H., Burns, B., Hiday, V., & Borum, R.
(1999). Can involuntary outpatient commitment reduce hospital recidivism:
Findings from a randomized trial with severely mentally ill individuals.
American Journal of Psychiatry 156:
1968-1975.
Swartz, M., Swanson, J.,
Steadman, H., Robbins, P., & Monahan J. (2009). New York state assisted outpatient treatment
program evaluation. Duke University School of Medicine.
[12]Gilbert,
A., Moser, L., Van Dorn, R., Swanson, J., Wilder, C., Robbins, P., Keator, K.,
Steadman, H., & Swartz, M. (2010). Reductions in arrest under assisted
outpatient treatment in New York.
Psychiatric
Services 61: 996-999.
[13]
New York State Office of Mental Health. 2005. Kendra’s Law: Final Report on the
Status of Assisted Outpatient Treatment.
[14]
Hiday, V., Swartz, M., Swanson, J., Borum, R., & Wagner, R. (2002). Impact
of outpatient commitment on victimization of people with severe mental
illness.
American Journal of Psychiatry, 159:
1403-1411.
[15]
Phelan, J., Sinkewicz, M., Castille, D., Huz, St., & Link, B. (2010).
Effectiveness and outcome of assisted outpatient treatment in New York state.
Psychiatric Services 61: 137-143.
[16]
New York State Office of Mental Health. 2005. Kendra’s Law: Final Report on the
Status of Assisted Outpatient Treatment.
[18]
Gilbert, A., Moser, L., Van Dorn, R., Swanson, J., Wilder, C., Robbins, P.,
Keator, K., Steadman, H., & Swartz, M. (2010). Reductions in arrest under
assisted outpatient treatment in New York.
Psychiatric
Services 61: 996-999.
[19]
Swanson, J., Van Dorn, R.,
Swartz, M.,
Robbins, P., Steadman, H., McGuire, T., & Monahan, J. (2013). The cost of
assisted outpatient treatment: Can it save states money?
American Journal of Psychiatry 170:1423-1432.